Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
+0.24%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$6.39B
AUM Growth
+$706M
(+12%)
Cap. Flow
+$747M
Cap. Flow
% of AUM
11.68%
Top 10 Holdings %
Top 10 Hldgs %
53.35%
Holding
886
New
91
Increased
283
Reduced
420
Closed
88
Top Buys
| 1 |
VanEck Gold Miners ETF
GDX
|
$495M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
$238M |
| 3 |
Invesco QQQ Trust
QQQ
|
$88.6M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
$60.9M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$59.2M |
Top Sells
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
$20.1M |
| 2 |
NVIDIA
NVDA
|
$20M |
| 3 |
iShares China Large-Cap ETF
FXI
|
$19.7M |
| 4 |
Texas Instruments
TXN
|
$18.3M |
| 5 |
Qualcomm
QCOM
|
$16.3M |
Sector Composition
| 1 | Financials | 10.54% |
| 2 | Energy | 6.9% |
| 3 | Healthcare | 6.34% |
| 4 | Technology | 6.19% |
| 5 | Real Estate | 3.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
126
DELISTED
Blueprint Medicines
BPMC
| $6.03M | 0.09% |
82,120
+27,608
| +51% | +$2.03M |
|
|
ONCE
127
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $6M | 0.09% |
61,872
+11,269
| +22% | +$1.09M |
|
128
Exelixis
EXEL
$10.1B
| $5.96M | 0.09% |
336,921
+85,952
| +34% | +$1.52M |
|
|
MRTX
129
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.9M | 0.09% |
75,767
+23,314
| +44% | +$1.82M |
|
130
Global X Robotics & Artificial Intelligence ETF
BOTZ
$2.81B
| $5.89M | 0.09% |
293,988
+106,631
| +57% | +$2.13M |
|
131
Travelers Companies
TRV
$62.9B
| $5.88M | 0.09% |
39,568
-6,271
| -14% | -$932K |
|
132
APA Corp
APA
$8.39B
| $5.88M | 0.09% |
229,739
+28,068
| +14% | +$719K |
|
133
Ionis Pharmaceuticals
IONS
$9.46B
| $5.88M | 0.09% |
98,163
+18,299
| +23% | +$1.1M |
|
134
Aflac
AFL
$58.1B
| $5.84M | 0.09% |
111,545
-17,617
| -14% | -$922K |
|
|
GBT
135
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $5.82M | 0.09% |
119,973
+28,385
| +31% | +$1.38M |
|
|
NVTA
136
DELISTED
Invitae Corporation
NVTA
| $5.76M | 0.09% |
298,986
+41,880
| +16% | +$807K |
|
137
Bank of New York Mellon
BK
$74.4B
| $5.73M | 0.09% |
126,833
-27,053
| -18% | -$1.22M |
|
|
SAGE
138
DELISTED
Sage Therapeutics
SAGE
| $5.69M | 0.09% |
40,561
+12,189
| +43% | +$1.71M |
|
139
Sarepta Therapeutics
SRPT
$1.93B
| $5.69M | 0.09% |
75,514
+34,167
| +83% | +$2.57M |
|
|
BLUE
140
DELISTED
bluebird bio
BLUE
| $5.68M | 0.09% |
4,774
+1,530
| +47% | +$1.82M |
|
141
MetLife
MET
$54.4B
| $5.65M | 0.09% |
119,789
-21,258
| -15% | -$1M |
|
|
MRO
142
DELISTED
Marathon Oil Corporation
MRO
| $5.64M | 0.09% |
459,920
+66,556
| +17% | +$817K |
|
143
Equity Residential
EQR
$25B
| $5.59M | 0.09% |
64,763
-8,849
| -12% | -$763K |
|
144
Prudential Financial
PRU
$38.3B
| $5.52M | 0.09% |
61,340
-10,167
| -14% | -$915K |
|
145
Exact Sciences
EXAS
$9.73B
| $5.51M | 0.09% |
60,983
+15,723
| +35% | +$1.42M |
|
|
XEC
146
DELISTED
CIMAREX ENERGY CO
XEC
| $5.49M | 0.09% |
114,428
+14,437
| +14% | +$692K |
|
147
AvalonBay Communities
AVB
$27.4B
| $5.3M | 0.08% |
24,606
-3,592
| -13% | -$773K |
|
|
BHVN
148
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $5.25M | 0.08% |
125,778
+48,518
| +63% | +$2.02M |
|
149
Amicus Therapeutics
FOLD
$2.47B
| $5.21M | 0.08% |
648,972
+213,367
| +49% | +$1.71M |
|
150
Moody's
MCO
$89.6B
| $5.09M | 0.08% |
24,850
-4,008
| -14% | -$821K |
|